Recently, Pharmadule Morimatsu AB successfully delivered the landmark EIPICO3 Modular Pharmaceutical Plant project. The successful completion of this project marks the perfect inauguration of Egypt's first modular biopharmaceutical plant integrating mixed production and filling functions for monoclonal antibodies and small molecule proteins, setting a new benchmark.

As one of the core pharmaceutical markets in the Middle East and North Africa region, Egypt has long faced the challenge of heavy reliance on imported biological products. EIPICO, a leading enterprise in Egypt's pharmaceutical sector, partnered with Pharmadule Morimatsu AB to build this advanced modular plant, which will bridge the technological gap in Egypt's high-end biopharmaceutical production and inject strong momentum into the development of the local healthcare industry.

In the early stages of the project, the joint participation of the design and project teams enhanced execution efficiency and controllability. All structural elements of the modules were manufactured in Pharmadule Morimatsu AB’s workshops in China before being shipped to Egypt for installation. Leveraging robust overall planning and design capabilities, as well as supply chain coordination and manufacturing proficiency, Pharmadule Morimatsu AB completed the production of 88 highly integrated modules in just 100 days. These modules encompassed critical facilities such as cleanrooms, process equipment, piping systems, ventilation systems, electrical controls, BMS&EMS management systems, fire alarm systems, and security systems. The on-site construction phase was equally efficient, with all 88 modules installed in 21 days, followed by successful Site Acceptance Testing (SAT) and system commissioning verification.

EIPICO Executives Visit the Project Site

Mr. Ahmed Kelani, Chairman and General Manager of EIPICO, spoke highly of Pharmadule Morimatsu AB, praising it as a "trustworthy and outstanding partner." He emphasized that Pharmadule Morimatsu AB possesses an exceptional and highly professional project team, consistently adhering to the highest industry standards and delivering outstanding quality. This has laid a solid foundation for deepening strategic collaboration and expanding future cooperation between both parties.

With the deepening advancement of the Belt and Road Initiative, trade cooperation between China and Egypt, as well as the broader African region, continues to strengthen. The successful completion of the EIPICO3 modular pharmaceutical plant not only marks a significant step forward for Egypt in the high-end biopharmaceutical sector but also stands as a fruitful achievement of China-Egypt cooperation under the Belt and Road framework. Pharmadule Morimatsu AB, in collaboration with EIPICO, is strengthening the foundation of Egypt's pharmaceutical and healthcare industry, opening a new chapter in making more accessible and higher-quality biopharmaceuticals available to the public, and jointly building a global model for a healthier future.

About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.